Perseon to Present at Rodman & Renshaw 17th Annual Global Investment Conference
September 21 2015 - 8:46PM
Perseon Corporation (NASDAQ:PRSN) ("Perseon" or the "Company"), a
leading provider of medical systems that utilize energy to treat
cancer, today announced that management will present at the Rodman
& Renshaw 17th Annual Global Investment Conference being held
at The St. Regis Hotel, New York City. Clint Carnell, Chief
Executive Officer, will provide an overview of Perseon and its
strategy at 11:40 a.m. Eastern time on Thursday, September 10,
2015.
Perseon's presentation will be webcast live and archived for 90
days on the Events and Presentations page at
http://perseonmedical.com.
About Perseon
Perseon Corporation invests its resources in fighting humanity's
worst disease: cancer. Perseon's people are dedicated to finding
innovative technologies and means to deliver energy solutions to
healthcare providers and patients around the world. MicroThermX®
treats soft tissue tumors with precision-focused energy, expanding
the options and broadening the opportunities for cancer
treatment.
Forward-Looking Statements
Statements contained in this press release that are not
historical facts, including statements relating to our focus on
microwave ablation to create stockholder value and pursuit of our
strategic plans are forward-looking statements, as defined in the
Private Securities Litigation Reform Act of 1995. All
forward-looking statements are subject to risks and uncertainties,
including the risk that for a variety of reasons we may not be able
to execute on our strategic plans, and other risks and
uncertainties detailed in the Company's filings with the Securities
and Exchange Commission. These forward-looking statements speak
only as of the date on which such statements are made, and the
Company undertakes no obligation to update such statements to
reflect events or circumstances arising after such date, except as
required by law.
CONTACT: Tricia Ross
Financial Profiles
310-622-8226
tross@finprofiles.com